# Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy

> **NCT00955929** · NA · TERMINATED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 76 (actual)

## Conditions studied

- Penile Cancer
- Erectile Dysfunction
- Radical Prostatectomy

## Interventions

- **DRUG:** Placebo QHS and sildenafil and questionnaires
- **DRUG:** Sildenafil and questionnaire
- **DRUG:** Trimix combination (Papavarine 30mg/mL Phentholamine 1mg/mL Prostaglandin E1 10 mcg/mmL) and questionnaires

## Key facts

- **NCT ID:** NCT00955929
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08-06
- **Primary completion:** 2020-12-09
- **Final completion:** 2020-12-09
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** The study was interrupted because of failure to recruit the target study population in a reasonable timeframe.
- **Last updated:** 2021-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955929, "Pharmacological Penile Rehabilitation in the Preservation of Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00955929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*